Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022
Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022
Secukinumab safe, effective in children with moderate to severe plaque psoriasis
31 Jan 2022
Treatment with either low- or high-dose secukinumab is effective and well tolerated in paediatric patients with moderate to severe plaque psoriasis, a study has shown.
Secukinumab safe, effective in children with moderate to severe plaque psoriasis
31 Jan 2022
Erenumab effective for migraine regardless of aura status
28 Jan 2022
bởiAudrey Abella
In a post hoc analysis, use of the anti-CGRP* receptor monoclonal antibody erenumab led to reduced migraine frequency and AMSM** days in individuals with migraine with and without a history of aura.